Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease

scientific article published on 17 June 2016

Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CCT.2016.06.004
P932PMC publication ID5024731
P698PubMed publication ID27327779

P50authorNancy S. GreenQ37840450
Suzanne BakkenQ61465965
P2093author name stringSusan L Rosenthal
Haomiao Jia
Arlene Smaldone
Deepa Manwani
Sally Findley
Sergio Matos
L Adriana Matiz
P2860cites workTransition and sickle cell diseaseQ26863538
Induction of fetal hemoglobin in sickle cell disease.Q33539271
Dyadic measures of the parent-child relationship during the transition to adolescence and glycemic control in children with type 1 diabetesQ33744978
Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV.Q33753905
How we design feasibility studiesQ33809081
How I use hydroxyurea to treat young patients with sickle cell anemiaQ33985120
Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflictQ34008123
Medication adherence among pediatric patients with sickle cell disease: a systematic review.Q34567690
Construct validity of the Work Productivity and Activity Impairment questionnaire across informal caregivers of chronically ill older patientsQ34580233
Hydroxyurea for the treatment of sickle cell anemiaQ34764729
Health-related quality of life in children and adolescents with sickle cell diseaseQ35072375
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).Q35097294
Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyureaQ35230853
Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?Q35234959
PedsQL™ sickle cell disease module: feasibility, reliability, and validityQ35545910
Measuring resource utilization in patient-oriented comparative effectiveness research: a psychometric study of the Resource Utilization QuestionnaireQ35612335
Role of habit in adherence to medical treatmentQ36078667
From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemiaQ36154109
Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomesQ36234033
Trust in physicians and racial disparities in HIV careQ36321589
Parental and other factors associated with hydroxyurea use for pediatric sickle cell diseaseQ36763705
Predictive validity of a medication adherence measure in an outpatient settingQ36925564
Community Health Workers as Support for Sickle Cell CareQ37032152
Differences in health-related quality of life in children with sickle cell disease receiving hydroxyureaQ37059877
Psychological aspects and hospitalization for pain crises in youth with sickle-cell diseaseQ37097814
Validity of the Pediatric Quality Of Life Inventory for youth with sickle cell diseaseQ37133670
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell diseaseQ37155243
The performance of the PedsQL generic core scales in children with sickle cell diseaseQ37155370
The role of lay health workers in pediatric chronic disease: a systematic reviewQ37242509
Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell diseaseQ37244000
The validity and reproducibility of a work productivity and activity impairment instrumentQ74822877
A framework for the study of self- and family management of chronic conditionsQ79207968
Identifying barriers to medication adherence in adolescent transplant recipientsQ80375574
The number of people with sickle-cell disease in the United States: national and state estimatesQ82320507
Community health worker insights on their training and certificationQ83147414
Shorter hospitalization trends among children with sickle cell diseaseQ83186797
Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizationsQ83572756
Population estimates of sickle cell disease in the U.S.Q83889628
Community health workers as drivers of a successful community-based disease management initiativeQ83931263
Text4Health: a qualitative evaluation of parental readiness for text message immunization remindersQ84734642
Building a consensus on community health workers' scope of practice: lessons from New YorkQ84809885
Allocation of family responsibility for illness management in pediatric HIV.Q37292613
Perceived barriers to clinic appointments for adolescents with sickle cell diseaseQ37361190
Adherence to hydroxyurea therapy in children with sickle cell anemiaQ37512157
Brief report: development of the inflammatory bowel disease family responsibility questionnaireQ37535314
Evaluating adherence to medication in children and adolescents with HIV.Q37590520
Influences on adherence to pediatric asthma treatment: a review of correlates and predictorsQ37649421
Medication adherence in the asthmatic child and adolescentQ37942016
Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trialQ38005665
Acute care utilization and rehospitalizations for sickle cell diseaseQ38374639
Hydroxyurea Use in Young Children With Sickle Cell Anemia in New York StateQ39672020
Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.Q39677885
The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected childrenQ39700582
Facilitators and barriers to self-management of type 2 diabetes among urban African American adults: focus group findingsQ39956165
Exploring pregnant women's views on influenza vaccination and educational text messagesQ39957532
Community-based care coordination: practical applications for childhood asthmaQ40006384
Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatmentQ40738128
Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysisQ41087808
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell diseaseQ41983509
Barriers to adherence of deferoxamine usage in sickle cell diseaseQ42642783
Treatment adherence in patients with sickle cell anemiaQ43200152
The allocation of family responsibility for asthma management tasks in African-American adolescentsQ43437947
Five years of experience with hydroxyurea in children and young adults with sickle cell diseaseQ43615402
Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetesQ44082230
PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populationsQ44207239
Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell diseaseQ44664007
At what age do children start taking daily asthma medicines on their own?Q45828982
Hydroxyurea use in patients with sickle cell disease in a Medicaid populationQ46046652
Mammography adherence and beliefs in a sample of low-income African American womenQ46628518
Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.Q48004843
Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.Q50972375
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.Q51065755
Supporting the health care transition from adolescence to adulthood in the medical home.Q51553770
Lessons learned from a community-academic initiative: the development of a core competency-based training for community-academic initiative community health workers.Q51781488
An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control.Q52897435
Mortality in sickle cell disease. Life expectancy and risk factors for early death.Q55065788
High resource hospitalizations among children with vaso-occlusive crises in sickle cell diseaseQ58883327
Assessing family sharing of diabetes responsibilitiesQ68632299
Deviation from developmentally appropriate self-care autonomy. Association with diabetes outcomesQ71286967
Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trialQ71571027
Medication adherence in pediatric asthma: reasoning, responsibility, and behaviorQ73529900
P407language of work or nameEnglishQ1860
P921main subjecthydroxycarbamideQ212272
randomized controlled trialQ1436668
sickle-cell diseaseQ185034
study protocolQ111908491
P304page(s)134-142
P577publication date2016-06-17
P1433published inContemporary Clinical TrialsQ5164971
P1476titleStudy protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease
P478volume49

Reverse relations

cites work (P2860)
Q92809941Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease
Q90727421HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol
Q52639727HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.
Q89988564Quality of Life of Latino and Non-Latino Youth With Sickle Cell Disease as Reported by Parents and Youth
Q48232192Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study
Q28066704Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis

Search more.